BI Asset Management Fondsmaeglerselskab’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Buy
7,925
+327
+4% +$64.2K 0.01% 451
2026
Q1
$1.49M Sell
7,598
-1,444
-16% -$281K 0.02% 431
2025
Q4
$1.57M Buy
9,042
+219
+2% +$39.9K 0.01% 457
2025
Q3
$1.68M Buy
8,823
+3,991
+83% +$708K 0.02% 439
2025
Q2
$868K Buy
4,832
+1,181
+32% +$205K 0.01% 510
2025
Q1
$618K Sell
3,651
-1,708
-32% -$281K 0.01% 540
2024
Q4
$808K Sell
5,359
-2,712
-34% -$422K 0.01% 556
2024
Q3
$1.25M Buy
8,071
+6,257
+345% +$934K 0.02% 351
2024
Q2
$248K Sell
1,814
-1,096
-38% -$150K ﹤0.01% 547
2024
Q1
$387K Buy
2,910
+270
+10% +$35K 0.01% 579
2023
Q4
$364K Sell
2,640
-2,428
-48% -$319K 0.01% 595
2023
Q3
$618K Sell
5,068
-4,639
-48% -$618K 0.01% 454
2023
Q2
$1.36M Buy
9,707
+1,507
+18% +$208K 0.03% 307
2023
Q1
$1.16M Sell
8,200
-81,376
-91% -$11.6M 0.03% 306
2022
Q4
$14M Buy
+89,576
New +$12.9M 0.37% 77
2021
Q2
Sell
-26,161
Closed -$3.36M 406
2021
Q1
$3.36M Buy
26,161
+9,999
+62% +$1.23M 0.14% 132
2020
Q4
$1.93M Buy
16,162
+6,521
+68% +$795K 0.08% 158
2020
Q3
$1.1M Sell
9,641
-2,895
-23% -$342K 0.05% 269
2020
Q2
$1.43M Sell
12,536
-538
-4% -$57.1K 0.07% 228
2020
Q1
$1.05M Buy
+13,074
New +$1.35M 0.06% 240

Other funds holding DGX

BI Asset Management Fondsmaeglerselskab's DGX Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its Quest Diagnostics (DGX) stake by 4.3% in Q2 2026, buying an estimated $64.2K and bringing the position to 7,925 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #451.

BI Asset Management Fondsmaeglerselskab first reported a position in DGX in Q1 2020 and has held it in 20 quarters since. The position peaked at $14M in Q4 2022. 750 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 7,925 shares of Quest Diagnostics worth $1.68M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 327 Quest Diagnostics shares in Q2 2026, an estimated $64.2K.
  • Quest Diagnostics made up 0.01% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #451 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Quest Diagnostics in Q1 2020 and has held it in 20 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Quest Diagnostics position peaked at $14M in Q4 2022.
  • 750 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.